The efficacy and safety of Epimedium in the treatment of primary osteoporosis: a systematic review and meta-analysis.
- 2025-09-19
- Systematic Review · n = 10
- Frontiers in medicine 12
- Xian-Quan Zhang
- Zhen-Hui Hua
- Chu-Jia Huang
- Hai-Yun Chen
- Zong-Ren Hu
- Mei-Ren Zhang
- Jun Liu
- PubMed: 41048931
- DOI: 10.3389/fmed.2025.1675160
- High evidence
- Clinical
bone-specific alkaline phosphatase (BALP) increased (MD = 6.73; 95% CI: 3.32,10.14; p = 0.0001)
- Effect
- Beneficial
- Effect size
- Large
- Significant
- Yes